Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Express 2008
Issue number 720: March 31, 2008
 
Contents of this Issue
Select a title to jump to the article.
  1. CDC website posts provisional recommendations for prevention and control of influenza in 2008-09
  2. March 2008 issue of Vaccinate Adults offers adult medicine specialists many immunization resources
  3. CDC responds to recent vaccine court case with an op-ed article in the Atlanta Journal Constitution
  4. Dr. Paul Offit's teleconference on issues related to recent media coverage of vaccine safety is available for downloading
  5. MMWR issues corrections to the Recommended Immunization Schedules for Persons Aged 0-18 Years--United States, 2008
  6. CDC revises its interactive immunization scheduler for children age 6 years and younger
  7. IAC website posts updated patient-education piece for young adults who are chronically infected with hepatitis B virus
  8. Important: Be sure to give influenza vaccine throughout the influenza season--from now through spring
  9. Single-dose vials of yellow fever vaccine now available
  10. FDA updates two tables in its "Thimerosal in Vaccines" online resource
  11. For coalitions: IZTA's April 10 teleconference to focus on working with the media to promote facts about vaccine safety
  12. Vaccine Safety Working Group meeting scheduled for April 11 in Washington, DC; the public is invited to attend
  13. MMWR reports on progress made toward eradicating polio in Pakistan and Afghanistan in 2007
  14. Chicago Area Immunization Campaign plans its Spring General Meeting for April 16
 
Abbreviations
AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; AMA, American Medical Association; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD, National Center for Immunization and Respiratory Diseases; NIVS, National Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
  
Issue 720: March 31, 2008
1.  CDC website posts provisional recommendations for prevention and control of influenza in 2008-09

On March 25, CDC posted "ACIP Provisional Recommendations for the Prevention and Control of Influenza" for the 2008-09 influenza season. Provisional recommendations are those ACIP has voted on but that are not yet approved by CDC or the Department of Health and Human Services and not yet published in MMWR. Once the influenza recommendations are approved, they are tentatively scheduled for MMWR publication in June 2008. Portions of the provisional recommendations are reprinted below.

  • Annual vaccination for all children aged 6 months through 18 years is recommended. Annual vaccination of children aged 6 months up to their fifth birthday (through 59 months of age) should continue. If feasible, annual vaccination of all children aged 5 years through 18 years should begin in 2008 when the vaccine for the 2008-2009 influenza season becomes available.
     
  • Annual vaccination for all children aged 6 months through 18 years should begin no later than during the 2009-2010 influenza season.
     
  • The Vaccines for Children Fund resolution is effective July 1, 2008
    (http://www.cdc.gov/vaccines/programs/vfc/downloads/resolutions/0208influenza.pdf).
     
  • Persons at higher risk of influenza complications because of underlying medical conditions, children aged 6 months through 23 months, and persons aged >49 years should receive TIV. Either trivalent inactivated influenza vaccine (TIV) or live, attenuated influenza vaccine (LAIV) should be used when vaccinating persons aged 2 through 49 years who do not have medical conditions that put them at higher risk for influenza complications.
     
  • Children aged 6 months through 8 years should receive two doses of influenza vaccine (doses separated by >=4 weeks) if they have not been vaccinated previously at any time with at least one dose of either LAIV or TIV.
     
  • Clinicians and immunization program staff should screen for possible reactive airway disease when considering use of LAIV for children aged 2 through 4 years, and should avoid use of this vaccine in children with asthma or a recent wheezing episode. The ACIP has previously provided recommendations on screening for possible reactive airway disease in children aged 2 through 4 years (http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5646a4.htm). . . .


To access the complete provisional recommendations, go to:
http://www.cdc.gov/vaccines/recs/provisional/downloads/flu-3-21-08-508.pdf

To access other provisional recommendations, go to:
http://www.cdc.gov/vaccines/recs/provisional

Back to top
   
2 March 2008 issue of Vaccinate Adults offers adult medicine specialists many immunization resources

IAC recently mailed the latest issue of Vaccinate Adults (March 2008) to 150,000 adult medicine specialists and others who work in the field of immunization. Packed with immunization and hepatitis resources, the 12-page issue is well worth downloading. All articles and education pieces, except editorials, have been reviewed by immunization and hepatitis experts at CDC.

You can view selected articles from the table of contents below or download the entire issue from the Web.

To download a ready-to-print (PDF) version of the entire issue, go to:
http://www.immunize.org/va/va21.pdf

The PDF file of the entire issue is large. For tips on downloading and printing PDF files, go to:
http://www.immunize.org/nslt.d/tips.htm

To view the table of contents with links to individual articles, go to:
http://www.immunize.org/va

The March issue includes several notable print resources on immunization and viral hepatitis, all of which can be downloaded:

  • Ask the Experts
     
  • Vaccine Administration Record for Adults
     
  • Hepatitis B Facts: Testing and vaccination
     
  • Recommended Adult Immunization Schedule, United States, October 2007-September 2008

If you would like to subscribe to the mail version of Vaccinate Adults, go to: http://www.immunize.org/subscribe Your subscription will begin with the autumn 2008 issue.

Back to top
   
3 CDC responds to recent vaccine court case with an op-ed article in the Atlanta Journal Constitution

On March 26, the Atlanta Journal Constitution published an op-ed article written by NCIRD's director, Anne Schuchat, MD. Titled "Vaccines' Benefits Outweigh Dangers: Autism claim shouldn't deter parents," the article states that since 1988, the National Vaccine Injury Compensation Program has provided compensation in about 2,100 cases. In no case was autism determined to be caused by a vaccine. During the same time frame, about 100 million U.S. children received recommended childhood immunizations.

The op-ed article is now posted on the CDC website. To access it, go to:
http://www.cdc.gov/news/2008/03/VaccineQuestions.html

Back to top
   
4 Dr. Paul Offit's teleconference on issues related to recent media coverage of vaccine safety is available for downloading

On March 14, Dr. Paul Offit spoke on a teleconference sponsored by the Pennsylvania chapter of AAP. Dr. Offit (1) described the weight of research on causes of autism, (2) summarized research on whether thimerosal or MMR vaccine cause autism, (3) described the National Vaccine Injury Compensation Program (VICP), (4) summarized the recent Poling VICP case and media coverage, and (5) described ways to address parents' vaccine concerns, in particular, requests for an extended vaccine schedule using individual antigens. Dr. Offit presented for approximately 25 minutes and answered about 15 minutes of caller questions.

Dr. Offit is chief of Infectious Diseases and director of the Vaccine Education Center at Children's Hospital of Philadelphia.

To download the teleconference mp3 file, go to: http://www.paiep.org In the section titled What's New, click on the link labeled "To listen to the talk (mp3 file) click here."

Back to top
   
5 MMWR issues corrections to the Recommended Immunization Schedules for Persons Aged 0-18 Years--United States, 2008

CDC published "Errata: Vol 57, No.1" in the March 28 issue of MMWR. The errata concern "Recommended Immunization Schedules for Persons Aged 0-18 Years--United States, 2008," which were published on January 11 as an MMWR QuickGuide. The errata are reprinted below in their entirety.


In "Recommended Immunization Schedules for Persons Aged 0-18 Years--United States, 2008," errors occurred.

On page Q-2, under Figure 1, in footnote 4, Haemophilus influenzae type b conjugate vaccine (Hib), the second bullet should read:
  • TriHiBit (DTaP/Hib) combination products should not be used for primary immunization but can be used as boosters after any Hib vaccine in children aged >=12 months.

On page Q-4, in the lower section of the Table titled, Catch-up schedule for persons aged 7-18 years, in row Human Papillomavirus, under column heading Dose 2 to Dose 3, the text should read:

12 weeks (and 24 weeks after the first dose)


To access a web-text (HTML) version of the errata, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5712a6.htm

To access a ready-to-print (PDF) version of this issue of MMWR, go to: http://www.cdc.gov/mmwr/PDF/wk/mm5712.pdf

To access a web-text (HTML) version of the January 11 QuickGuide, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5701a8.htm

To receive a FREE electronic subscription to MMWR (which includes new ACIP statements), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html

Back to top
   
6 CDC revises its interactive immunization scheduler for children age 6 years and younger

On March 25, the NCIRD website posted an updated interactive Childhood Immunization Scheduler for children age 6 years and younger. It is based on the 2008 Childhood and Adolescent Immunization Schedule.

Parents who use the interactive scheduler are cautioned that the information it contains may not be accurate for a child who has a condition that affects the immune system. Parents are also encouraged to consult a clinician for advice on their child's immunization needs.

To access the scheduler, go to:
http://www2a.cdc.gov/nip/kidstuff/newscheduler_le

Back to top
   
7 IAC website posts updated patient-education piece for young adults who are chronically infected with hepatitis B virus

Sarah Jane Schwarzenberg, MD, and Karen Y. Wainwright, RN, recently made minor changes to their patient-education piece "You are not alone! Information for young adults who are chronically infected with hepatitis B virus."

The revised piece is posted on the IAC website. To access it,go to: http://www.immunize.org/catg.d/p4118.pdf

Back to top
   
8 Important: Be sure to give influenza vaccine throughout the influenza season--from now through spring

Influenza is currently circulating, and vaccination should continue from now through May. Visit the following websites often to find the information you need to keep vaccinating. Both are continually updated with the latest resources.

The National Influenza Vaccine Summit website at
http://www.preventinfluenza.org

CDC's Seasonal Flu web section at http://www.cdc.gov/flu

Back to top
   
9 Single-dose vials of yellow fever vaccine now available

On March 26, CDC's Travelers' Health web section announced that yellow fever vaccine is now available in single-dose vials. In the recent past, there was a temporary shortage of the vaccine in the single-dose presentation. Portions of the March 26 announcement are reprinted below.


In March 2008, the Centers for Disease Control and Prevention (CDC) was informed by sanofi pasteur, the only manufacturer of U.S. yellow fever vaccine, that the single-dose vials of yellow fever vaccine, YF-VAX, are now available. Limitations on orders will be in place as sanofi pasteur works to build inventory of the single-dose vials.

In the interim, the 5-dose vials of YF-VAX continue to be available in sufficient supply. To accommodate all travelers who need this vaccine, clinics administering vaccine are advised to attempt to schedule vaccinations to efficiently use the 5-dose vials.

According to the manufacturer's package insert, YF-VAX must be used within one hour of reconstitution. . . .

For Further Information
Contact telephone number for sanofi pasteur ([800] 822-2463).

Please visit the Travelers' Health website [http://wwwn.cdc.gov/travel] for further updates on availability of yellow fever vaccine.

To access the announcement, go to:
http://wwwn.cdc.gov/travel/contentYellowFeverVaccineShortage.aspx

Back to top
   
10.  FDA updates two tables in its "Thimerosal in Vaccines" online resource

FDA recently updated two tables in its online resource "Thimerosal in Vaccines." They are "Table 2. Preservatives in US. Licensed Vaccines" and "Table 3. Thimerosal and Expanded List of Vaccines."

To access the updated tables, go to: http://www.fda.gov/cber/vaccine/thimerosal.htm and click on the pertinent link in the table of contents.

Back to top
   
11.  For coalitions: IZTA's April 10 teleconference to focus on working with the media to promote facts about vaccine safety

The Immunization Coalitions Technical Assistance Network (IZTA) April 10 conference call is titled "Misperceptions, Raw Emotions, Potent Strategies: Working with Traditional and New Media to Promote the Facts about Vaccine Safety." IZTA is a program of the Center for Health Communication, Academy for Educational Development.

The April 10 call will be held at 2PM, ET. To register, send an email to izta@aed.org Include this message: "Sign me up for the promoting vaccine safety call."

For additional information, or to access earlier programs, go to: http://www.izta.org/confcall.cfm

Back to top
   
12.  Vaccine Safety Working Group meeting scheduled for April 11 in Washington, DC; the public is invited to attend

The Federal Register for March 24 included an announcement of the April 11 meeting of the Vaccine Safety Working Group of the National Vaccine Advisory Committee (NVAC). The meeting, which is open to the public, is planned for Washington, DC. Pre-registration is required for both public attendance and comment. Any individual who wishes to attend the meeting and/or participate in the public comment session should contact the designated staff member, Daniel Salmon, by email at daniel.salmon@hhs.gov or call him at (202) 690-5566.

The meeting announcement includes details of the meeting's content. To access the announcement directly, go to: http://regulations.justia.com/view/106050

To access the announcement, as well as background information on the Immunization Safety Office Scientific Agenda, go to: http://www.cdc.gov/od/science/iso/agenda.htm The announcement is located in the section titled "Who will review the ISO Scientific Agenda." Click on the link titled "meeting" for the announcement.

Back to top
   
13.  MMWR reports on progress made toward eradicating polio in Pakistan and Afghanistan in 2007

CDC published "Progress Toward Poliomyelitis Eradication--Pakistan and Afghanistan, 2007" in the March 28 issue of MMWR. A portion of press summary of the article is reprinted below.


Pakistan and Afghanistan share borders in remote areas of both countries with rugged terrain and constant population movements across borders. In 2007, limited progress was made toward interrupting wild poliovirus [WPV] transmission in Pakistan-Afghanistan. In Afghanistan, in August 2007 the support of antigovernment groups was obtained, which increased access to areas for vaccinators during immunization campaigns in the south region. However, despite intensive efforts, both type 1 and type 3 wild poliovirus continue to circulate into 2008 in areas of both countries. Access to children is limited by ongoing conflicts and security concerns in remote border areas of both countries. In other WPV-endemic areas of Pakistan, where security and access concerns do not exist, operational problems in implementing immunization activities resulted in inadequate vaccination of children. Further progress will require continued efforts for both issues.


To access a web-text (HTML) version of the complete article, go to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5712a3.htm

To access a ready-to-print (PDF) version of this issue of MMWR, go to: http://www.cdc.gov/mmwr/PDF/wk/mm5712.pdf

Back to top
   
14.  Chicago Area Immunization Campaign plans its Spring General Meeting for April 16

April 16 is the date for the Chicago Area Immunization Campaign's Spring General Meeting. It will be held at the University of Illinois at Chicago.

To download the conference brochure, go to:
http://www.ilmaternal.org/CAIC/Misc/Spring08Mtgbrochure.pdf

For additional information, contact Melissa Ponce at (312) 491-8161.

Back to top
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.